Dare Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Dare Bioscience, Inc. (Nasdaq: DARE) on June 14, 2019, regarding events occurring on June 13, 2019. The company is an emerging growth company incorporated in Delaware. The report details the final results of the annual meeting of stockholders held on June 13, 2019.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes
No material financial changes were reported in this filing. The primary event was the completion of the annual stockholder meeting, resulting in the election of directors and the ratification of the independent auditor.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly reports the vote tallies for the matters submitted to stockholders.
Key Facts for Investor Verification
- Director Elections: Stockholders elected three Class II nominees to the Board of Directors for a three-year term expiring in 2022: Gregory W. Matz, William H. Rastetter, Ph.D., and Robin J. Steele, J.D. LLM.
- Voting Results for Directors:
- Gregory W. Matz: 4,883,460 votes For; 92,021 votes Withheld.
- William H. Rastetter: 4,654,985 votes For; 320,496 votes Withheld.
- Robin J. Steele: 4,654,635 votes For; 320,846 votes Withheld.
- Auditor Ratification: Stockholders ratified the appointment of Mayer Hoffman McCann P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Voting Results for Auditor: 11,341,328 votes For; 383,799 votes Against; 121,916 Abstentions.
- Broker Non-Votes: There were 6,871,562 broker non-votes recorded for the director elections and zero broker non-votes for the auditor ratification.